International Flavors & Fragrances Inc
Change company Symbol lookup
Select an option...
IFF International Flavors & Fragrances Inc
NEMD iNeedMD Holdings Inc
CVS CVS Health Corp
CMI Cummins Inc
INVH Invitation Homes Inc
OII Oceaneering International Inc
SINO Sino-Global Shipping America Ltd
MLM Martin Marietta Materials Inc
KO Coca-Cola Co
VICI VICI Properties Inc
Go

Materials : Chemicals | Mid Cap Blend
Company profile

International Flavors & Fragrances Inc. provides products that consumers taste, smell, or touch. It operates through three segments: Taste, Frutarom and Scent. Taste is comprised of Flavor Compounds which are sold to the food and beverage industries for use in consumer products, such as prepared foods, beverages, dairy, food and sweet products. Frutarom segment creates and manufactures a naturals-focused suite of flavor compounds, functional foods and specialty fine ingredients. Scent segment is comprised of Fragrance Compounds, which are used by its customers in two broad categories: Fine Fragrances and Consumer Fragrances; Fragrance Ingredients, which consists of synthetic and natural ingredients that can be combined with other materials to create fragrance and consumer compounds; and Cosmetic Active Ingredients, consisting of active and functional ingredients, botanicals and delivery systems.

Closing Price
$102.66
Day's Change
-0.26 (-0.25%)
Bid
--
Ask
--
B/A Size
--
Day's High
103.35
Day's Low
101.41
Volume
(Average)
Volume:
1,564,092

10-day average volume:
1,554,239
1,564,092

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Immunomedics, Inc. - IMMU

8:00 pm ET September 18, 2020 (PR Newswire) Print

Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Immunomedics, Inc. ("Immunomedics" or the "Company") (IMMU) relating to the sale of the Company to Gilead Sciences, Inc. Under the terms of the agreement, Immunomedics shareholders are anticipated to receive $88.00 per share for each share of Immunomedics they own.

https://mma.prnewswire.com/media/443626/Monteverde_Associates_PC_Logo.jpg

Click here for more information: https://www.monteverdelaw.com/case/immunomedics-inc. It is free and there is no cost or obligation to you.

The investigation focuses on whether Immunomedics and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company's stockholders by 1) failing to conduct a fair process, 2) whether and by how much this proposed transaction undervalues the Company and 3) failing to disclose all material information.

About Monteverde & Associates PC

We are a national class action securities litigation law firm that has recovered millions of dollars and is committed to protecting shareholders from corporate wrongdoing. Our lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions. Mr. Monteverde is recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019, an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2019 Top Rated Lawyer. Our firm's recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019). Also, in 2019 we recovered or secured six cash common funds for shareholders in mergers & acquisitions class action cases.

If you own common stock in Immunomedics, Inc. and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:Juan E. Monteverde, Esq.MONTEVERDE & ASSOCIATES PCThe Empire State Building 350 Fifth Ave. Suite 4405New York, NY 10118United States of Americajmonteverde@monteverdelaw.com Tel: (212) 971-1341

Attorney Advertising. (C) 2020 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

https://c212.net/c/img/favicon.png?sn=DC29002&sd=2020-09-18

View original content to download multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-monteverde--associates-pc-announces-an-investigation-of-immunomedics-inc--immu-301134120.html

SOURCE Monteverde & Associates PC

https://rt.prnewswire.com/rt.gif?NewsItemId=DC29002&Transmission_Id=202009182000PR_NEWS_USPR_____DC29002&DateId=20200918

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.